PULSE BIOSCIENCES, INC.
PLSE · XNASCIK 1625101fmd_1YP0CBJ19P3NK6XVWFDMYVM16FManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2015 to Sep 30, 2026, 47 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | 1 | 1 | 0 | 0 | 0 |
| Net interest income | 0 | 0 | 0 | 1 | 0 | – | – | – | – | – |
| Cost of revenue | 1 | 1 | 1 | 1 | 0 | 2 | 12 | 0 | 0 | 1 |
| Gross profit | – | – | – | – | 0 | (1) | (11) | 0 | 0 | (0) |
| Research and development | 6 | 10 | 17 | 25 | 26 | 29 | 21 | 28 | 32 | 45 |
| Selling, general and administrative | – | – | – | – | – | – | – | – | 24 | 32 |
| Total operating expenses | 10 | 26 | 38 | 48 | 50 | – | – | – | – | – |
| Operating income | (10) | (26) | (38) | (48) | (50) | (63) | (58) | (44) | (56) | (77) |
| Other non-operating income (expense) | – | – | – | 1 | 0 | (1) | (0) | 1 | 3 | 4 |
| Income before taxes | – | – | (38) | (47) | (50) | (64) | (59) | (42) | 54 | 73 |
| Income tax expense | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | – | – | – | (50) | (64) | (59) | (42) | 54 | 73 |
| Net income | (10) | (26) | (38) | (47) | (50) | (64) | (59) | (42) | (54) | (73) |